Vorinostat in Combination With Vinorelbine in Patients With Advanced Cancer

NCT00801151 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Malignant Solid Tumour

Interventions

DRUG: Zolinza (vorinostat), vinorelbine

Sponsor

Institut Claudius Regaud

Collaborators

[object Object]